Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $242.5 million.

  • Ironwood Pharmaceuticals' Total Current Liabilities rose 39106.58% to $242.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.5 million, marking a year-over-year increase of 39106.58%. This contributed to the annual value of $38.8 million for FY2024, which is 8593.05% down from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Total Current Liabilities stood at $242.5 million, which was up 39106.58% from $232.5 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Total Current Liabilities registered a high of $305.4 million during Q2 2023, and its lowest value of $23.3 million during Q2 2022.
  • Moreover, its 5-year median value for Total Current Liabilities was $134.4 million (2021), whereas its average is $130.7 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Total Current Liabilities soared by 121079.92% in 2023 and then plummeted by 8593.05% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Total Current Liabilities (Quarter) stood at $161.7 million in 2021, then tumbled by 84.21% to $25.5 million in 2022, then skyrocketed by 981.69% to $276.1 million in 2023, then crashed by 85.93% to $38.8 million in 2024, then skyrocketed by 524.27% to $242.5 million in 2025.
  • Its last three reported values are $242.5 million in Q3 2025, $232.5 million for Q2 2025, and $48.1 million during Q1 2025.